| Scott M Fair, DO | |
|
2000 Palm Beach Lakes Blvd Ste 400, West Palm Beach, FL 33409-6504 | |
| (561) 561-1500 | |
| Not Available |
| Full Name | Scott M Fair |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 10 Years |
| Location | 2000 Palm Beach Lakes Blvd Ste 400, West Palm Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700278710 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0107X | Ophthalmology - Retina Specialist | OS14637 (Florida) | Secondary |
| 207W00000X | Ophthalmology | OS14637 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mittleman Eye Center Pa | 8628974730 | 8 |
News Archive
High-grade serious ovarian carcinoma (HGSOC) is the fifth-leading cause of cancer-related deaths in women in the United States, yet little is known about the origins of this disease.
Astellas today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis), life-threatening fungal infections predominantly occurring in immunocompromised patients.
Alcon, the world's leader in eye care, announced today that it will purchase the rights in the United States for two FDA-approved topical eye care products from Sirion Therapeutics, Inc. The two products purchased are Durezol™, a marketed ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, and Zirgan™, a recently approved antiviral for the treatment of acute herpetic keratitis (corneal ulcers).
Aegis Analytical Corp., the leading provider of Enterprise Manufacturing and Process Intelligence software, announced today the availability of Aegis Discoverant® 4.0, the latest version of its global software platform.
› Verified 4 days ago
| Entity Name | Mittleman Eye Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518097401 PECOS PAC ID: 8628974730 Enrollment ID: O20031210000152 |
News Archive
High-grade serious ovarian carcinoma (HGSOC) is the fifth-leading cause of cancer-related deaths in women in the United States, yet little is known about the origins of this disease.
Astellas today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis), life-threatening fungal infections predominantly occurring in immunocompromised patients.
Alcon, the world's leader in eye care, announced today that it will purchase the rights in the United States for two FDA-approved topical eye care products from Sirion Therapeutics, Inc. The two products purchased are Durezol™, a marketed ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, and Zirgan™, a recently approved antiviral for the treatment of acute herpetic keratitis (corneal ulcers).
Aegis Analytical Corp., the leading provider of Enterprise Manufacturing and Process Intelligence software, announced today the availability of Aegis Discoverant® 4.0, the latest version of its global software platform.
› Verified 4 days ago
| Entity Name | University Of Miami |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013967827 PECOS PAC ID: 3274795109 Enrollment ID: O20200406001006 |
News Archive
High-grade serious ovarian carcinoma (HGSOC) is the fifth-leading cause of cancer-related deaths in women in the United States, yet little is known about the origins of this disease.
Astellas today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis), life-threatening fungal infections predominantly occurring in immunocompromised patients.
Alcon, the world's leader in eye care, announced today that it will purchase the rights in the United States for two FDA-approved topical eye care products from Sirion Therapeutics, Inc. The two products purchased are Durezol™, a marketed ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, and Zirgan™, a recently approved antiviral for the treatment of acute herpetic keratitis (corneal ulcers).
Aegis Analytical Corp., the leading provider of Enterprise Manufacturing and Process Intelligence software, announced today the availability of Aegis Discoverant® 4.0, the latest version of its global software platform.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott M Fair, DO 2000 Palm Lakes Blvd, 400, West Palm Beach, FL 33409-6504 Ph: (561) 500-2020 | Scott M Fair, DO 2000 Palm Beach Lakes Blvd Ste 400, West Palm Beach, FL 33409-6504 Ph: (561) 561-1500 |
News Archive
High-grade serious ovarian carcinoma (HGSOC) is the fifth-leading cause of cancer-related deaths in women in the United States, yet little is known about the origins of this disease.
Astellas today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis), life-threatening fungal infections predominantly occurring in immunocompromised patients.
Alcon, the world's leader in eye care, announced today that it will purchase the rights in the United States for two FDA-approved topical eye care products from Sirion Therapeutics, Inc. The two products purchased are Durezol™, a marketed ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, and Zirgan™, a recently approved antiviral for the treatment of acute herpetic keratitis (corneal ulcers).
Aegis Analytical Corp., the leading provider of Enterprise Manufacturing and Process Intelligence software, announced today the availability of Aegis Discoverant® 4.0, the latest version of its global software platform.
› Verified 4 days ago
Nunzio P Sossi, M.D..PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 130 Butler St, West Palm Beach, FL 33407 Phone: 561-832-6113 Fax: 561-833-3003 | |
Steven Edens, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2000 Palm Beach Lakes Blvd Ste 400, West Palm Beach, FL 33409 Phone: 561-500-2020 | |
Mr. Salomon Emilio Melgen, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2521 Metrocentre Blvd, West Palm Beach, FL 33407 Phone: 561-687-0007 Fax: 561-688-0431 | |
Mr. Norman C Johnson Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1500 N Dixie Hwy, #200, West Palm Beach, FL 33401 Phone: 561-832-3774 Fax: 561-832-4082 | |
Dr. Michael Patipa, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4461 Medical Center Way, Suite A, West Palm Beach, FL 33407 Phone: 561-845-6500 Fax: 561-845-6300 | |
Richard Michael Kadingo, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1515 N Flagler Dr, Ste 500, West Palm Beach, FL 33401 Phone: 561-659-9700 Fax: 561-659-7153 | |
Jodi Ian Luchs, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1515 N Flagler Dr Ste 500, West Palm Beach, FL 33401 Phone: 561-659-9700 Fax: 561-659-7153 |